Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Equine Pregnancy Protein Discovered
Horse-Trust funded research finds protein that may help maintain equine pregnancy.
 
A research project funded by The Horse Trust has discovered for the first time the expression of a protein in horses known to be important in maintaining pregnancy.

Infertility and foetal loss are a significant problem within the equine industry, causing distress to both the mares and the owners. The cause of loss is unknown in around 20% of cases.

The research aimed to understand more about how pregnancy is maintained in horses and to investigate further into how equine herpevirus may trigger foetal loss.

The project was undertaken by Dr Lucy Woolford at the Royal Veterinary College, who now works as a Lecturer in Veterinary Pathology at the University of Adelaide, Australia.

Maintaining a viable pregnancy is dependent on the ability of the mother's immune system to 'tolerate' the immunologically 'foreign' foetus. The ways in which mares tolerate the developing foetus is not fully understand, but in humans, primates and mice a protein called indoleamine 2,3-dioxygenase (IDO) produced by the pregnant uterus has been shown to be important.

Dr Woolford said she believes the research is "the first study ever to describe the expression and localisation of IDO in equine tissues."

She added: "More research is needed to understand the immunology of pregnancy and how IDO might contribute to maintenance of pregnancy in mares. More research is also needed to further understand how equine causes foetal loss."

Her research so far has been submitted for publication in a veterinary journal.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'